Filtros de búsqueda

Lista de obras de Eva Poveda

A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.

artículo científico publicado en 2011

A2 Optimization of the results generated by large-scale sequencing for the study of drug resistance in HIV infection: A systematic review.

artículo científico publicado en 2018

Antiretroviral Treatment for HIV Elite Controllers?

artículo científico publicado en 2020

Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?

artículo científico publicado en 2015

Any risk for HIV patients posed by the novel influenza A (H7N9)?

artículo científico publicado el 1 de abril de 2013

Are fusion inhibitors active against all HIV variants?

artículo científico publicado en 2004

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.

artículo científico publicado en 2011

Brief Report: European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression Among HCV and HIV/HCV-Coinfected Patients From Northwest Spain.

artículo científico publicado en 2016

Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?

artículo científico publicado en 2003

Cancer Incidence in Persons Living With HIV

scientific article published on 14 November 2016

Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study

artículo científico publicado en 2019

Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain

artículo científico publicado en 2009

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir

artículo científico publicado en 2008

Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.

artículo científico publicado en 2017

Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance.

artículo científico publicado en 2017

Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues

scientific article published on 01 January 2011

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

artículo científico publicado en 2012

Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use

artículo científico publicado en 2007

Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response

artículo científico publicado en 2022

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection

artículo científico publicado en 2021

Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.

artículo científico publicado en 2009

Diagnosis and treatment outcomes of adult tuberculosis in an urban setting with high human immunodeficiency virus prevalence in Sierra Leone: A retrospective cohort study

scientific article published on 24 April 2020

Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

artículo científico publicado en 2004

Directly acting antivirals against hepatitis C virus

artículo científico publicado en 2011

Discovery of VIRIP--a natural HIV entry inhibitor.

artículo científico publicado en 2007

Discovery of a Natural Defense Against HIV With Therapeutic Potential

artículo científico publicado en 2015

Do interleukin-28B single nucleotide polymorphisms influence the natural history of chronic hepatitis B?

artículo científico publicado en 2010

Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy

artículo científico publicado en 2010

Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia

artículo científico publicado en 2010

Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy.

artículo científico publicado en 2007

Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy

artículo científico publicado en 2005

Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels

artículo científico publicado en 2022

Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels

artículo científico publicado en 2022

Enfuvirtide is active against HIV type 1 group O.

artículo científico publicado en 2005

Enfuvirtide, the first fusion inhibitor to treat HIV infection.

artículo científico publicado en 2005

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

artículo científico publicado en 2010

Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes

artículo científico publicado en 2008

Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes

artículo científico publicado en 2008

Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure

artículo científico publicado en 2004

Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor

artículo científico publicado en 2002

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists

scientific article published on July 2010

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study.

artículo científico publicado en 2014

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.

artículo científico publicado en 2016

HBV primary drug resistance in newly diagnosed HIV–HBV-coinfected individuals in Spain

article

HIV entry inhibitors: mechanisms of action and resistance pathways

artículo científico publicado en 2006

HIV entry into the cells--mechanisms and therapeutic possibilities

artículo científico publicado en 2006

HIV tropism shift: new paradigm on cell therapy strategies for HIV cure

artículo científico publicado en 2015

HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors

artículo científico publicado en 2006

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

artículo científico publicado en 2014

HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic

article

HTLV infection in HCV-antibody positive patients in Spain

artículo científico publicado en 2017

Hepatitis B in HIV-infected patients

artículo científico

Hepatitis B virus and HIV infection

artículo científico publicado en 2012

Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain

artículo científico publicado en 2013

Hepatitis C therapy with HCV NS5B polymerase inhibitors

artículo científico publicado en 2013

Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver

artículo científico publicado en 2012

Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves

artículo científico publicado en 2013

Hepatitis delta in HIV-infected individuals in Europe

artículo científico publicado en 2011

High Prevalence of Late-Stage Disease in Newly Diagnosed Human Immunodeficiency Virus Patients in Sierra Leone

scientific article published on 23 August 2018

High concordance between the position-specific scoring matrix and geno2pheno algorithms for genotypic interpretation of HIV-1 tropism: V3 length as the major cause of disagreement

artículo científico

High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor

artículo científico publicado en 2010

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response

artículo científico publicado en 2014

High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists

artículo científico publicado en 2010

Highlights from CROI 2014 on experimental HIV drugs

artículo científico publicado en 2014

Hot News: Exosomes as New Players in HIV Pathogenesis - New Data from the IAS 2017.

artículo científico publicado en 2017

Hot News: Impact of Low-level Viremia on Treatment Outcomes During ART - Is it Time to Revise the Definition of Virological Failure?

artículo científico publicado en 2018

Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years

artículo científico publicado en 2008

Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients

artículo científico publicado en 2011

Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.

artículo científico publicado en 2007

Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.

artículo científico publicado en 2011

Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients.

artículo científico publicado en 2010

Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials

artículo científico publicado en 2007

Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

artículo científico publicado en 2009

Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected

artículo científico publicado en 2017

Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.

artículo científico publicado en 2013

Ingenol derivates promising for HIV eradication.

artículo científico publicado en 2014

Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user

artículo científico publicado en 2008

Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors.

artículo científico publicado en 2017

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines

scientific article published on 01 January 2019

Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.

artículo científico publicado en 2017

Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain

artículo científico publicado en 2016

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

artículo científico

Lung cancer in patients living with HIV infection

article

Massive release of CD9+ microvesicles in HIV infection, regardless of virologic control

artículo científico publicado en 2020

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers

artículo científico publicado en 2014

Methods for determination of HIV tropism and their clinical use

artículo científico publicado en 2011

Methods for determining viral tropism: genotype and phenotype tests

artículo científico publicado en 2008

Minimizing Next-Generation Sequencing Errors for HIV Drug Resistance Testing

artículo científico publicado en 2017

Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak.

artículo científico publicado en 2014

Multi-step inhibition against HIV lifecycle-underlying the "magic" of protease inhibitors

artículo científico publicado en 2014

Nationwide Study of Drug Resistance Mutations in HIV-1 Infected Individuals under Antiretroviral Therapy in Brazil ⬇️

artículo científico

Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients

artículo científico publicado en 2011

New Insights into HIV-1 Persistence in Sanctuary Sites During Antiretroviral Therapy

artículo científico publicado en 2016

New Strategies for a Comprehensive Fight Against HIV Infection using Monoclonal Antibody Therapy

artículo científico publicado en 2016

New resistance score for tipranavir.

artículo científico publicado en 2008

News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference

artículo científico publicado en 2015

News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference

artículo científico publicado en 2017

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients

artículo científico publicado en 2012

Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc ⬇️

artículo científico publicado el 19 de marzo de 2010

Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters

artículo científico publicado en 2008

Pharmacogenetics of hepatitis C.

artículo científico publicado en 2011

Pharmacokinetics, interactions and mechanism of action of maraviroc

artículo científico publicado en 2008

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues

artículo científico publicado en 2008

Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication.

artículo científico publicado en 2017

Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain

artículo científico publicado en 2011

Prevalence of Hepatitis B Surface Antigen and Serological Markers of other Endemic Infections in HIV-infected Children, Adolescents and Pregnant Women in Sierra Leone: A Cross-sectional Study

scientific article published on 28 September 2020

Prevalence of NS5A Resistance Associated Substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on Current Therapeutic Strategies

artículo científico publicado en 2018

Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

artículo científico publicado en 2007

Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

scientific article published on 23 July 2007

Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.

artículo científico publicado en 2019

Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors

artículo científico publicado en 2007

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

artículo científico publicado en 2012

Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients

artículo científico publicado en 2010

Raltegravir and etravirine are active against HIV type 1 group O.

artículo científico publicado en 2009

Rapid Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O

scientific article published in 2003

Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.

artículo científico publicado en 2002

Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor

artículo científico publicado en 2003

Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients

artículo científico publicado en 2017

Resistance to entry inhibitors

Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

artículo científico publicado en 2013

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

artículo científico publicado en 2010

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

artículo científico publicado en 2013

Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

artículo científico publicado en 2013

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing

artículo científico publicado en 2014

Seroprevalence of Hepatitis B, Hepatitis C, and Human T-Cell Lymphotropic Virus Infections in HIV-Infected Patients in Sierra Leone

scientific article published on 01 June 2019

Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration

artículo científico publicado en 2017

Short communication: Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B?

artículo científico publicado en 2012

Short communication: severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regions

artículo científico publicado en 2011

Similar Immunological Profiles Between Nonprogressing HIV Infection in Children and Nonpathogenic SIV Infection

artículo científico publicado en 2017

Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors

artículo científico publicado en 2006

Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

artículo científico publicado en 2019

Targeting gap junctional intercellular communication by hepatocarcinogenic compounds

scientific article published on 22 June 2020

Telaprevir resistance

artículo científico publicado en 2013

The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts.

artículo científico publicado en 2015

The changing face of hepatitis C in the new era of direct-acting antivirals.

artículo científico publicado en 2012

Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor

scientific article published on 01 June 2003

Treatment failure with new hepatitis C drugs

artículo científico

Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

article

Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infection

artículo científico publicado en 2016

Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years.

artículo científico publicado en 2015

Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists.

artículo científico publicado en 2012

Update on hepatitis C virus resistance to direct-acting antiviral agents

artículo científico publicado en 2014

Variabilidad en la determinación del tropismo viral del VIH utilizando diferentes algoritmos genotípicos de interpretación en pacientes VIH-1 infectados con subtipos B versus no-B

artículo científico publicado en 2011

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C.

artículo científico publicado en 2013

Viral resistance and genetic barrier of atazanavir

artículo científico publicado en 2008

When is Early Antiretroviral Therapy Early Enough for HIV Remission?

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda